| NCT Number | NCT07520279 |
| Lead Sponsor | Cepheid |
| Conditions | Malaria Fever, Zika, Dengue Fever, Leptospirosis, Chikungunya Virus Infection |
| Enrollment | 2,500 participants |
| Start Date | 2025-08-18 |
| Primary Completion | 2026-08-31 (estimated) |
| Study Completion | 2027-02-28 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-09 |